Why the study?
Minimally invasive direct coronary artery bypass has been routinely utilized for left anterior descending coronary artery revascularization, but how this procedure has evolved required examination.
Does contemporary robot-assisted MIDCAB improve short-term outcomes compared to historical open-harvest MIDCAB in patients requiring LAD revascularization?
Cohort (n=2,283)
Does contemporary robot-assisted MIDCAB improve short-term outcomes compared to historical open-harvest MIDCAB in patients requiring LAD revascularization?
Answers are grounded in this paper and cite their sources.
Over a 25-year period, MIDCAB patients presented with fewer comorbidities (except diabetes), and the transition to robot-assisted LIMA harvest was associated with a lower risk of stroke.
Objective: We have routinely utilized minimally invasive direct coronary artery bypass (MIDCAB) for revascularization of the left anterior descending (LAD) coronary artery. We examined how this procedure has evolved. Methods: A retrospective review was undertaken of 2,283 consecutive patients who underwent MIDCAB between 1997 and 2021. Patients were divided into 3 groups: group A from 1997 to 2002 ( n = 751, 32.9%), group B from 2003 to 2009 ( n = 452, 19.8%), and group C from 2009 to 2021 ( n = 1,080, 47.3%). Risk profiles and short-term outcomes were analyzed for the entire cohort and for 293 propensity-matched patients drawn from each group. Results: The left internal mammary artery was harvested open in group A but with robotic assistance in group C. Thirty-day mortality was higher in group A versus group C (12 deaths, 1.6% vs 5 deaths, 0.5%, P = 0.044); this difference was negated after propensity matching. Group A had more comorbidities than group C, including peripheral vascular disease (17.7% vs 10.0%, P < 0.001), congestive heart failure (39.6% vs 18.0%, P < 0.001), and a history of stroke (17.9% vs 10.0%, P < 0.001), although diabetes mellitus was more common in group C (51.4% vs 31.0%, P < 0.001). Stroke was greater in group A (1.2% vs 0.0% vs 0.2%, respectively, P = 0.004), as was the need for prolonged ventilation (3.6% vs 0.2% vs 0.9%, respectively, P < 0.001), before and after propensity matching. Conclusions: MIDCAB patients had less comorbidities than in the past. Robot-assisted MIDCAB was associated with lower stroke risk.
No takes yet. Share an insight, caveat, or question.
Varrone et al. (2022) conducted a cohort in Coronary artery disease requiring LAD revascularization (n=2,283). Robot-assisted MIDCAB (Group C, 2009-2021) vs. Open MIDCAB (Group A, 1997-2002) was evaluated on Stroke (p=0.004).
Synapse has enriched 10 related papers. Consider them for comparative context: